NASDAQ:VMD
Viemed Healthcare, Inc.
Viemed Healthcare, Inc.'s revenue grew 20.5% in fiscal 2025 to $270.3M while operating margin rose to 8.5%. Free cash flow was $11.9M, 4.4% of revenue.Summary generated from Viemed Healthcare, Inc.'s SEC filings. Latest annual report filed Mar 4, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$270.3M
Revenue growth+20.5%
Revenue, 5-yr CAGR+15.5%
Gross margin57.5%
Operating margin8.5%
Net margin5.5%
ROIC12.6%
Return on equity10.9%
Debt / equity0.09
Free cash flow$11.9M
FCF margin4.4%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 117 | 139 | 183 | 224 | 270 |
| Operating income | 12 | 8 | 14 | 18 | 23 |
| Net income | 9 | 6 | 10 | 11 | 15 |
| Free cash flow | 3 | 5 | 19 | 1 | 12 |
Recent filings
- 8-KRegulation FD disclosure
Aug 20, 2026 - 4Insider transaction report
Aug 19, 2026 - 4Insider transaction report
Aug 19, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 3, 2026 - 8-KResults of operations and financial condition
Aug 3, 2026 - 8-KDirector or officer change
Jun 4, 2026 - 8-KRegulation FD disclosure
Jun 2, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026